GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care to Consider Q1 FY27 Unaudited Financial Results
RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 28 Jul 2026, 06:59 PM IST  ·  BSE ID: b4c6bb2a-1623-428b-b101-af7e8fd2c857
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet on August 4, 2026, to review its first-quarter financial performance.
🤖 AI Summary
  • Board of Directors meeting scheduled for Tuesday, August 04, 2026, to approve Unaudited Financial Results.
  • Unaudited Financial Results for the quarter ended June 30, 2026, for Standalone and Consolidated entities.
  • Company to host an Earnings/Analyst Conference Call on August 04, 2026, at 05:30 P.M. IST.
  • Trading window remains closed until 48 hours after financial results announcement.
  • Management representatives on conference call include Dr. Adil Agarwal (CEO) and Mr. Yashwanth Venkat (CFO).
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this intimation.
👤
Who Is Affected
All shareholders will be affected by the upcoming financial results, which will provide an update on the company's performance for the quarter ended June 30, 2026.
🔍
Management Signal
Management is signaling a commitment to timely financial disclosures and investor communication through the scheduled board meeting and earnings call.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Dr. Agarwals Health Care Q1 FY27 Unaudited Financial Results on August 04, 2026.
Transcript/recording of the Earnings/Analyst Conference Call on August 04, 2026.
Any further disclosures regarding operational performance for the June 2026 quarter.
LOW RISK This is a routine disclosure about an upcoming board meeting, carrying minimal inherent risk.
💡 Investor Takeaway
Dr. Agarwals Health Care's Board will convene on August 04, 2026, to consider and approve its Unaudited Financial Results for the quarter ended June 30, 2026. An analyst call is also scheduled for the same day to discuss these results.
📅 Company Track Record
In its previous filing on May 27, 2026, Dr. Agarwals Health Care reported a total income of INR 2,125 crores for FY26, representing a 20.9% year-on-year increase.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is Dr. Agarwals Health Care's Board Meeting scheduled?
The meeting of the Board of Directors of Dr. Agarwals Health Care Limited is scheduled for Tuesday, August 04, 2026.
What is the purpose of the upcoming Board Meeting for Dr. Agarwals Health Care?
The Board Meeting is scheduled, inter alia, to consider and approve the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2026.
When will Dr. Agarwals Health Care host its Earnings/Analyst Conference Call?
The company will host an Earnings/Analyst Conference Call on August 04, 2026, from 05:30 P.M. (IST) to 06:30 P.M. (IST).
Who will represent Dr. Agarwals Health Care on the earnings call?
Dr. Adil Agarwal (Whole-time Director and CEO), Mr. Yashwanth Venkat (Chief Financial Officer), and Ms. Aashna Dharia (Head, Investor Relations) will represent the company.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.